BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2006
View Archived Issues
Fluoglizine more potent than fluoxetine in a mouse model of depression/anxiety
Read More
Neuroprotective effects of RWJ-333369 shown in a rat status epilepticus model
Read More
Emisphere and Roche establish multiproduct research collaboration
Read More
Inex to complete spin-out of Tekmira in September
Read More
Russian sites cleared to participate in BiovaxID phase III study
Read More
Xceleron to conduct phase 0 microdose study for Biofrontera Bioscience
Read More
Nerviano Medical Sciences to scale up Indena compounds
Read More
DNAPrint Genomics signs research agreement with Beth Israel Deaconess
Read More
DAC selects Evotec as partner for Hsp90 discovery project
Read More
ProtoKinetix' AAGP protects cells while preserving normal cell function
Read More
Alteon shareholders approve HaptoGuard merger
Read More
ImClone and Merck amend and supplement Erbitux agreement
Read More
New phase II study evaluates HGS-ETR1 with bortezomib in multiple myeloma
Read More
AVI BioPharma modifies HCV study of AVI-4065
Read More
CF-101 begins phase IIb for rheumatoid arthritis
Read More
CellTran and Innogenetics negotiate combining wound care activities
Read More
Nikken Chemical launches Selenica R tablet 400 mg in Japan
Read More
New glia-targeting clinical candidate presented with efficacy in AD
Read More
Nexavar approved in Europe for advanced renal cell carcinoma
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
Novel therapeutic agents for metabolic disorders reported
Read More
Symbicort receives FDA approval
Read More
New TGF-beta antagonists prepared and tested by Korean scientists
Read More
Tysabri available in U.S. for relapsing MS
Read More
TaiGen Biotechnology reports initial preclinical data of its novel agent against SARS virus
Read More
Tygacil now available in U.K.
Read More
Lansoprazole in chronic postnasal drip to be evaluated in clinical study / News in Context
Read More
Important antinociceptive actions of PPC-5383, a novel acid-sensing ion channel blocker
Read More
Promising preclinical results of novel Abeta fibril-disrupting agents developed at ProteoTech
Read More
Protective effects of dactylorhin B against beta amyloid-induced brain mitochondrial toxicity
Read More